Accelerating the Future of Diabetes: Investment, Innovation, and the Path to a Cure

​Finding a cure for diabetes will require more than scientific break throughs, it will require a new model for bringing together ideas, investment, and people. As the catalyst, University Hospital Foundation is convening partners and investing in platforms dedicated to accelerating diabetes research and innovation, like DiaCell who is mobilizing capital, and engaging the community to help move promising discoveries closer to life-changing therapies.

​This panel will explore how strategic investment and cross-sector collaboration can bridge the gap between laboratory discoveries and real-world impact. Bringing together leaders from research, healthcare, industry, philanthropy, and investment, the discussion will examine the innovations shaping the future of diabetes research, the importance of building a connected innovation ecosystem, and how collective action can accelerate progress toward better treatments and ultimately, a cure.

Panelists:
- Dr. Jodi Abbott, President & CEO, University Hospital Foundation
- Melanie Hibbard, Executive Director, DRIFCan and Director, DiaCell
- Dr. Christian Shuetz, Senior Research Associate, University of Alberta
Moderator:
- Gail Stepanik-Keber, Chief Catalyst, Marketing & Strategic Alliances, University Hospital Foundation